If you have ADHD or think you might:
The A.D.D. Resource Center can help!

Same Presentation, Different Code: Race and the ADHD Workup (HCP’s)

ADHD is not a different condition across racial groups, but the route to the diagnosis is. Black children are markedly less likely to be diagnosed with ADHD and markedly more likely to be coded with a disruptive behavior disorder on comparable presentations, and the recent national rise in diagnosis has not reached them. Much of the divergence is built into the informant data before the clinician sees the patient: parent and teacher ratings differ in a race-patterned way, so treating rater agreement as confirmation inherits the gap. The corrective is already in the AAP guideline. A second risk runs the opposite way in some school systems, where accountability pressure has been shown to push low-performing students toward disability classification. Six changes in reading, sequence, and attention are described, none of which lengthen the visit, along with one dermatologic caution specific to the methylphenidate patch.

Your ADHD Codes Survived FY2027 Intact. ICD-11 Is Where the Crosswalk Breaks. (HCPs only)

A working code list for ADHD and the conditions that travel with it, in all three systems at once.
Important: Read Before Using This List

This list of DSM-5-TR, ICD-10-CM, and ICD-11 codes is provided for general informational and educational purposes only. It is provided “as is,” without warranty of any kind, express or implied, including any warranty as to accuracy, completeness, currency, or fitness for a particular purpose.

Do not rely on this list without first verifying every code yourself against the official, current sources, such as the American Psychiatric Association’s DSM-5-TR, the CDC/NCHS ICD-10-CM code set, and the World Health Organization’s ICD-11. Coding systems are revised on a regular schedule, and this list may contain errors, omissions, or outdated entries. Additions, deletions, and corrections are likely over time.

We may or may not update this list. If we do, we make no commitment as to when or how often, and the absence of an update does not mean the list is current.

This is not medical, psychiatric, diagnostic, billing, or coding advice. It is not a substitute for professional judgment, and it must not be used to diagnose, to treat, or to submit claims. Diagnosis and coding decisions belong to qualified, licensed professionals working from the official sources. To the fullest extent permitted by law, The ADD Resource Center and its author accept no responsibility or liability for any loss, harm, or consequence arising from the use of, or reliance on, this list.

RSD, rejection sensitivity, or social anxiety: How to tell the difference

Social anxiety, rejection sensitivity, and RSD get blurred together. Here is what each one means, how to tell them apart, and where ADHD fits.

ADHD Isn’t an Attention Problem. Here’s What That Actually Changes.

A widely syndicated New York Times piece late last month asked whether ADHD is really about attention. It is a fair question, and not a new one. Volkow and colleagues concluded in Molecular Psychiatry in 2010 that “disruption of the dopamine reward pathway is associated with motivation deficits in ADHD adults, which may contribute to attention deficits.”

Same Prescription, Older Body: What Changes When You Add ADHD Medication to an Aging Regimen

A woman in her late sixties gets a late-in-life ADHD diagnosis, finally explaining a lifetime of scattered focus. Her prescriber starts a low dose of a stimulant. She’s also taking a blood pressure medication, a statin, something for sleep, and an antidepressant her internist added two winters ago.

The DEA’s New Telemedicine Rule: Why Your/Your Child’s Prescriber Might Not Be on the Approved List

A federal rule that will permanently govern telemedicine prescribing of ADHD stimulant medication is now in final White House review, with a decision expected around November 2026 — just before the temporary flexibility that currently allows it expires on December 31, 2026. The last public draft of the rule would have limited video-visit prescribing of Schedule II medications to seven specialist categories, including psychiatrists, pediatricians, and neurologists, but not family medicine or internal medicine physicians, who prescribe and manage a substantial share of ADHD medication nationally. Because the final rule’s text is not public, families cannot yet know whether this restriction survives, but the timeline leaves little room to adjust if it does. Parents are advised to confirm their prescriber’s specialty now and ask about contingency plans well before the December deadline.

The Session That Should Have Been Your Last: Deciding When Treatment Has Finished Its Work

There is an old line that you never know what is enough until you have had too much. It is a fine description of appetite and a poor description of treatment, and the difference between the two is worth understanding before your next appointment.

You have been going for a while now. A year, maybe three. The sessions are useful in the way that a good conversation is useful. Nothing is worse. Nothing is dramatically better either, at least not lately. And when you ask yourself whether you still need to be there, you find you cannot answer, so you keep the next appointment, because keeping it is easier than deciding.

Your therapist, psychiatrist, psychologist, or coach cannot answer it easily either. That is not a knock on them. It is a documented feature of the work, and it has a shape worth knowing.

On being blind and having ADHD

The widely repeated finding that vision impairment raises ADHD risk comes almost entirely from people with low vision. In the one study that separated the two groups, blind participants had a lower rate than the low-vision participants, and within the sample ADHD went with better acuity, not worse. Being blind does not appear to make you more likely to have ADHD. It makes you far more likely to have it missed.

Online and Overseas Pharmacies: What They Can (and Can’t) Do for You

Harold Robert Meyer The ADD Resource Center Reviewed: August 18, 2026 · Published: August 22, 2026 Prescription costs push a lot of people toward a website that promises the same drug for a fraction of the price. Before you click “order,” here is what the law, the evidence, and your own insurer actually say. Key … Read more

Three providers, three opinions: who coordinates, who weighs in, and who decides

Your prescriber adjusts the dose. Your therapist thinks the problem is anxiety, not dosing. Your child’s teacher reports the afternoons are worse than the mornings, and nobody has told the prescriber, because nobody asked the teacher. Each of these people is competent. Each is working from a fragment. And each of them assumes, quietly, that someone else has the whole file.

/* Clarify tracking https://clarity.microsoft.com/ */